Search Results
, Kállay K, Marosvári D, et al. Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia. [Familiáris myelodysplasiás szindróma és akut myeloid leukaemia klinikai és genetikai
.: Geographic distribution of patients with acute myeloid leukaemia in Szabolcs-Szatmár-Bereg county (analysis of data of a 32-year period). [Akut myeloid leukaemiás betegek lakóhely szerinti megoszlása
Nemecek ER, Hilger RA, Adams A, et al. Treosulfan, fludarabine, and low-dose total body irradiation for children and young adults with acute myeloid leukemia or myelodysplastic syndrome undergoing allogeneic
neoplasms and acute leukemia. Blood 2016; 127: 2391−2405. 10 Jakó J, Szerafin L. Geographic distribution of patients with acute myeloid leukemia in Szabolcs-Szatmár-Bereg county
, CAS CAS - Amp-B Outcome (as a cause of death) Died Unknown Died Died Survived Survived Survived Survived M: Male; F: Female; ICU: Intensive Care Unit; AML: Acute Myeloid Leukemia; FZ: Fluconazole; Amp-B: Amphotericin-B; VZ: Voriconazole; CAS
, E.R. & Koistinen, P. (2001): HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukaemia. Transfusion , 41 , 828–831. Koistinen P. HFE
Yeghen, T., Fenelon, L., Campbell, C.K., Warnock, D.W., Hoffbrand, A.V., Prentice, H.G., Kibbler, C.C.: Chaetomium pneumonia in patient with acute myeloid leukemia. J Clin Pathol 49 , 184–186 (1996). Kibbler CC
, et al. Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis. Int J Mol Sci. 2017; 18: 597
myeloid leukemia: a systematic review and meta-analysis. Biol. Blood Marrow Transplant., 2016, 22 (4), 651–657. 25 Perez, L. E.: Outcomes from unrelated donor
chronic myeloproliferative disorders. Blood, 2005, 106 (6), 2162–2168. Levine, R. L., Loriaux, M., Huntly, B. J., et al.: The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid
